ReviewPrevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies
Section snippets
Prevalence of Malnutrition
Patients with chronic diseases frequently become malnourished; they have an inability to meet macronutrient and micronutrient requirements through oral intake.5 Inadequate intake and/or associated malabsorption alters body composition and diminishes biological functions.5 Parameters used to assess malnutrition in patients with liver disease include anthropometric and serum measurements and qualitative data on weight history and food intake.6, 7
Malnutrition is common in patients with advanced
Etiology of Malnutrition
The etiology of malnutrition is multifactorial and primarily related to reduced liver function; poor oral intake and complications of cirrhosis such as ascites and hepatic encephalopathy also contribute.
Nutrition Assessment
Because nutrition is correlated with outcome of patients with liver disease, it is important to accurately assess nutritional status and provide timely nutritional support. This task is challenging, due to the complications of altered rates of protein metabolism and presence of ascites and edema. The European Society of Clinical Nutrition and Metabolism (ESPEN) 2006 guideline recommends the use of the subjective global assessment (SGA), anthropometry analysis, or the handgrip strength test to
Nutrition Recommendations
Current nutritional recommendations aim to provide patients with cirrhosis with sufficient energy intake for daily activities, the increased energy requirements associated with liver disease, to prevent further protein catabolism for energy, and to meet nutritional requirements, based on recommended daily intake. The recommendations proposed in the literature reflect the higher nutritional needs of patients with advanced liver disease, who have impaired nutrient absorption, and altered micro-
What About Parenteral Nutrition?
Total parenteral nutrition (TPN) should be restricted to patients that have contraindications to oral or enteral nutrition and to situations whereby adequate oral or enteral caloric intake is not being met despite best efforts. Patients who receive parenteral nutrition are at risk for infections—particularly catheter-related infections. Patients with advanced liver disease are also at risk for infections, because of alterations in intestinal permeability and endotoxemia; the presence of foreign
Conclusions
Many different factors contribute to malnutrition in patients with chronic liver disease. Impaired hepatocyte functions disrupt the nutrient balance and metabolism, which (in addition to ascites, protein catabolism, and nutrient deficiencies) can lead to hepatic encephalopathy. Studies have shown that early detection and treatment of malnutrition is imperative to improve patient outcomes. In addition to current recommendations for macro- and micronutrient supplementation, the therapeutic uses
References (82)
- et al.
Does malnutrition affect survival in cirrhosis?PINC (Policentrica Italiana Nutrizione Cirrosi)
Hepatology
(1996) - et al.
Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients
Nutrition
(2005) - et al.
Hypermetabolism in clinically stable patients with liver cirrhosis
Am J Clin Nutr
(1999) - et al.
Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study
Am J Clin Nutr
(2007) - et al.
Ascites increases the resting energy expenditure in liver cirrhosis
Gastroenterology
(1991) - et al.
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis
Hepatology
(2003) - et al.
Pancreas and liver injury are associated in individuals with increased alcohol consumption
Clin Gastroenterol Hepatol
(2009) - et al.
Diminishede micellular phase lipid in patients with chronic non-alcoholic liver disease and steatorrhea
Gastroenterology
(1970) - et al.
Absorption and transport of dietary long-chain fatty acids in cirrhosis: a stable-isotope-tracing study
Am J Clin Nutr
(2005) - et al.
Quantification of gluconeogenesis in cirrhosis: response to glucagon
Gastroenterologist
(1998)
Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure
Am J Clin Nutr
Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites
Clin Gastroenterol Hepatol
Gender dependent alterations in serum leptin in alcoholic cirrhosis
Gastroenterology
Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis
Hepatology
Hypothalamic mechanisms in cachexia
Physiol Behav
Taste perception in cirrhosis: its relationship to circulating micronutrients and food preferences
Hepatology
High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR)
Alcohol
Weighed dietary intakes in patients with chronic liver disease
Nutrition
Fat-soluble vitamin levels in patients with primary biliary cirrhosis
Am J Gastroenterol
Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin
Clin Nutr
ESPEN guidelines on enteral nutrition: liver disease
Clin Nutr
Subjective global assessment is not sufficient to screen patients with defective hepatic metabolism
Nutrition
BCAA-enriched snack improves nutritional state of cirrhosis
Nutrition
A combined high fiber, low glycemic index diet normalizes glucose tolerance and reduces hyperglycemia and hyperinsulinemia in adults with hepatic cirrhosis
J Am Diet Assoc
Normal protein diet for episodic hepatic encephalopathy: results of a randomized study
J Hepatol
Fat-soluble vitamins and their importance in patients with cholestatic liver diseases
Gastroenterol Clin North Am
Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy
J Hepatol
Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study
Nutrition
Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy
Lancet
Nutritional supplementation with branched-chain amino acid in advanced cirrhosis: a double blind, randomized trial
Gastroenterology
Effects of oral branched chain amino acid granules on event-free survival in patients with liver cirrhosis
Clin Gastroenterol Hepatol
Branched-chain amino acids: metabolism, physiological function, and application
J Nutr
Comparison of enteral feeding and total parenteral nutrition after liver transplantation
Lancet
ESPEN Guidelines on Parenteral Nutrition: hepatology
Clin Nutr
Malnutrition in end stage liver disease: recommendation and nutritional support
J Gastroenterol Hepatol
Nutritional support in alcoholic cirrhotic patients improves host defenses
J Am Coll Nutr
Anthropometric, biochemical and clinical assessment of malnutrition in Malaysian patients with advanced cirrhosis
Nutr J
Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee
JPEN J Parenter Enteral Nutr
Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation
Transplantation
Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis
Arq Gastroenterol
Nutritional status: its influence on the outcome of patients undergoing liver transplantation
Liver Int
Cited by (261)
Impact of Biopsy Proven Liver Fibrosis on Patients Undergoing Evaluation and Treatment for Advanced Heart Failure Surgical Therapies
2023, American Journal of CardiologyApproaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis
2024, Journal of Clinical and Translational HepatologyGrowth Hormone Therapy in Decompensated Cirrhosis: An Open-Label, Randomized Control Trial
2024, American Journal of Gastroenterology
This article has an accompanying continuing medical education activity on page e18. Learning Objective—At the end of this activity, the learner will appreciate that morbidity and mortality is related to nutritional status in patients with advanced liver disease; recognize the multifactorial nature of malnutrition in patients with cirrhosis; and appreciate the importance of the liver in the many derangements of nutritional status in patients with cirrhosis.
Conflicts of interest The authors disclose no conflicts.